US20060188453A1 - Use of substitute 2,4-bis (alkylamino)pyrimidines - Google Patents
Use of substitute 2,4-bis (alkylamino)pyrimidines Download PDFInfo
- Publication number
- US20060188453A1 US20060188453A1 US10/565,545 US56554506A US2006188453A1 US 20060188453 A1 US20060188453 A1 US 20060188453A1 US 56554506 A US56554506 A US 56554506A US 2006188453 A1 US2006188453 A1 US 2006188453A1
- Authority
- US
- United States
- Prior art keywords
- alkyl
- alkylamino
- formula
- compound
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC.CC.CC1=C(C)C=CC=C1.[1*]C1=NC(N([3*])[4*])=NC(N([5*])[6*])=C1[2*] Chemical compound CC.CC.CC1=C(C)C=CC=C1.[1*]C1=NC(N([3*])[4*])=NC(N([5*])[6*])=C1[2*] 0.000 description 7
- JUHLEBNMSGETPZ-UHFFFAOYSA-N CC.CC.CC1=C(C)C=CC=C1 Chemical compound CC.CC.CC1=C(C)C=CC=C1 JUHLEBNMSGETPZ-UHFFFAOYSA-N 0.000 description 2
- QSBDGSDBFWGXIN-UHFFFAOYSA-N CC1=CC(NCCC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=N1 Chemical compound CC1=CC(NCCC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=N1 QSBDGSDBFWGXIN-UHFFFAOYSA-N 0.000 description 2
- BFYOKXWZOUGXQF-UHFFFAOYSA-N CCCCCCCCCCCCNC1=CC(C)=NC(NC2=CC=CC=C2)=N1 Chemical compound CCCCCCCCCCCCNC1=CC(C)=NC(NC2=CC=CC=C2)=N1 BFYOKXWZOUGXQF-UHFFFAOYSA-N 0.000 description 2
- NFBCNDPNSGKJLX-UHFFFAOYSA-N CCCCCCCCNC1=CC(CCC)=NC(NCCCCCCCC)=N1 Chemical compound CCCCCCCCNC1=CC(CCC)=NC(NCCCCCCCC)=N1 NFBCNDPNSGKJLX-UHFFFAOYSA-N 0.000 description 2
- TYUXDTKHBLJUAE-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCC2=CC=CC=C2)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCC2=CC=CC=C2)=CC(C(C)(C)C)=N1 TYUXDTKHBLJUAE-UHFFFAOYSA-N 0.000 description 2
- UJZZTHCTMVUQCR-UHFFFAOYSA-N CCCCN(CCCC)C1=CC(C)=NC(NC2=CC=CC=C2)=N1 Chemical compound CCCCN(CCCC)C1=CC(C)=NC(NC2=CC=CC=C2)=N1 UJZZTHCTMVUQCR-UHFFFAOYSA-N 0.000 description 2
- XQXPQZMMJUPPQD-NGYSIMOBSA-N B.C.CCCCCCCCNC(=N)N.CCCCCCCCNC1=NC(Cl)=CC(C)=N1.CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1.CCCCCCCCNC1=NC(O)=CC(C)=N1.[2HH].[CH2+]OC(=O)CC(C)=O.[Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y]P([Y])[Y] Chemical compound B.C.CCCCCCCCNC(=N)N.CCCCCCCCNC1=NC(Cl)=CC(C)=N1.CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1.CCCCCCCCNC1=NC(O)=CC(C)=N1.[2HH].[CH2+]OC(=O)CC(C)=O.[Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y]P([Y])[Y] XQXPQZMMJUPPQD-NGYSIMOBSA-N 0.000 description 1
- VHGBBEDBPXPXLC-UHFFFAOYSA-N C.C.CCCCCCC(C(C)=O)C(=O)OC.CCCCCCCCNC(=N)N.CCCCCCCCNC1=NC(Cl)=C(CCCCCC)C(C)=N1.CCCCCCCCNC1=NC(NCCOCCOCCN)=C(CCCCCC)C(C)=N1.CCCCCCCCNC1=NC(O)=C(CCCCCC)C(C)=N1.F.[Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y]P([Y])[Y] Chemical compound C.C.CCCCCCC(C(C)=O)C(=O)OC.CCCCCCCCNC(=N)N.CCCCCCCCNC1=NC(Cl)=C(CCCCCC)C(C)=N1.CCCCCCCCNC1=NC(NCCOCCOCCN)=C(CCCCCC)C(C)=N1.CCCCCCCCNC1=NC(O)=C(CCCCCC)C(C)=N1.F.[Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y]P([Y])[Y] VHGBBEDBPXPXLC-UHFFFAOYSA-N 0.000 description 1
- JWVKQJSTPQPWLS-UHFFFAOYSA-N C1=CC=C(CNC2=CC(C3=CC=CC=C3)=NC(NC3=CC=CC=C3)=N2)C=C1 Chemical compound C1=CC=C(CNC2=CC(C3=CC=CC=C3)=NC(NC3=CC=CC=C3)=N2)C=C1 JWVKQJSTPQPWLS-UHFFFAOYSA-N 0.000 description 1
- ZHVILDUKEFLQIU-UHFFFAOYSA-N CC1=CC(NC(C)CC(C)C)=NC(NC(C)CC(C)C)=N1 Chemical compound CC1=CC(NC(C)CC(C)C)=NC(NC(C)CC(C)C)=N1 ZHVILDUKEFLQIU-UHFFFAOYSA-N 0.000 description 1
- OTEYDVXTQBPLOL-UHFFFAOYSA-N CC1=CC(NCC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=N1 Chemical compound CC1=CC(NCC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=N1 OTEYDVXTQBPLOL-UHFFFAOYSA-N 0.000 description 1
- NZRXKVOATWTKAR-UHFFFAOYSA-N CC1=NC(NC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1 Chemical compound CC1=NC(NC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1 NZRXKVOATWTKAR-UHFFFAOYSA-N 0.000 description 1
- UTYDHTLLJSYTBJ-UHFFFAOYSA-N CC1=NC(NC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1 Chemical compound CC1=NC(NC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1 UTYDHTLLJSYTBJ-UHFFFAOYSA-N 0.000 description 1
- UKMFKRNCWPJRQN-UHFFFAOYSA-N CC1=NC(NCC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1.CC1=NC(NCCC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1.CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1.CCCCCCCCNC1=NC(NCCOCCOCCC)=C(CCCCCC)C(C)=N1 Chemical compound CC1=NC(NCC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1.CC1=NC(NCCC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1.CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1.CCCCCCCCNC1=NC(NCCOCCOCCC)=C(CCCCCC)C(C)=N1 UKMFKRNCWPJRQN-UHFFFAOYSA-N 0.000 description 1
- UKCMGHUWACBBSD-UHFFFAOYSA-N CC1=NC(NCC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1.CC1=NC(NCCC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1.CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1.CCCCCCCCNC1=NC(NCCOCCOCCN)=C(CCCCCC)C(C)=N1 Chemical compound CC1=NC(NCC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1.CC1=NC(NCCC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1.CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1.CCCCCCCCNC1=NC(NCCOCCOCCN)=C(CCCCCC)C(C)=N1 UKCMGHUWACBBSD-UHFFFAOYSA-N 0.000 description 1
- GCPLIQNCEBKCOD-UHFFFAOYSA-N CCCC1=NC(N(C)C)=NC(NCCC2=CC=CC=C2)=C1 Chemical compound CCCC1=NC(N(C)C)=NC(NCCC2=CC=CC=C2)=C1 GCPLIQNCEBKCOD-UHFFFAOYSA-N 0.000 description 1
- YFGPJDKDXRRCQH-UHFFFAOYSA-N CCCC1=NC(NC2=CC=CC=C2)=NC(N2CCCC2)=C1 Chemical compound CCCC1=NC(NC2=CC=CC=C2)=NC(N2CCCC2)=C1 YFGPJDKDXRRCQH-UHFFFAOYSA-N 0.000 description 1
- DOGIIQZESIMJOA-UHFFFAOYSA-N CCCC1=NC(NC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1 Chemical compound CCCC1=NC(NC2=CC=CC=C2)=NC(NCC2=CC=CC=C2)=C1 DOGIIQZESIMJOA-UHFFFAOYSA-N 0.000 description 1
- TTWGPWYSSUFMAM-UHFFFAOYSA-N CCCC1=NC(NC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1 Chemical compound CCCC1=NC(NC2=CC=CC=C2)=NC(NCCC2=CC=CC=C2)=C1 TTWGPWYSSUFMAM-UHFFFAOYSA-N 0.000 description 1
- HXMKYIULMGJJAE-UHFFFAOYSA-N CCCCCCC1=C(N2CCCC2)N=C(N(C)C)N=C1C Chemical compound CCCCCCC1=C(N2CCCC2)N=C(N(C)C)N=C1C HXMKYIULMGJJAE-UHFFFAOYSA-N 0.000 description 1
- BVJZDQREBJATHO-UHFFFAOYSA-N CCCCCCC1=C(N2CCCC2)N=C(NC2=CC=CC=C2)N=C1C Chemical compound CCCCCCC1=C(N2CCCC2)N=C(NC2=CC=CC=C2)N=C1C BVJZDQREBJATHO-UHFFFAOYSA-N 0.000 description 1
- NMHVZYMMPGCALN-UHFFFAOYSA-N CCCCCCC1=C(NCC2=CC=CC=C2)N=C(NC2=CC=CC=C2)N=C1C Chemical compound CCCCCCC1=C(NCC2=CC=CC=C2)N=C(NC2=CC=CC=C2)N=C1C NMHVZYMMPGCALN-UHFFFAOYSA-N 0.000 description 1
- DAHWTQVNJYEPQQ-UHFFFAOYSA-N CCCCCCC1=C(NCCCN(CC)CC)N=C(NC2=CC=CC=C2)N=C1C Chemical compound CCCCCCC1=C(NCCCN(CC)CC)N=C(NC2=CC=CC=C2)N=C1C DAHWTQVNJYEPQQ-UHFFFAOYSA-N 0.000 description 1
- FMVCYEBYPYSXPB-UHFFFAOYSA-N CCCCCCC1=C(NCCOCCO)N=C(NC)N=C1C Chemical compound CCCCCCC1=C(NCCOCCO)N=C(NC)N=C1C FMVCYEBYPYSXPB-UHFFFAOYSA-N 0.000 description 1
- JZGZSDLQFIPNLU-UHFFFAOYSA-N CCCCCCCCCCCCCC1=NC(C)=CC(NCCCCCCCCCCCC)=N1 Chemical compound CCCCCCCCCCCCCC1=NC(C)=CC(NCCCCCCCCCCCC)=N1 JZGZSDLQFIPNLU-UHFFFAOYSA-N 0.000 description 1
- XAEQWRPTDSXXKP-UHFFFAOYSA-N CCCCCCCCCCCCNC1=CC(C)=NC(N(C)C)=N1 Chemical compound CCCCCCCCCCCCNC1=CC(C)=NC(N(C)C)=N1 XAEQWRPTDSXXKP-UHFFFAOYSA-N 0.000 description 1
- JQBMXIZEJZXVFH-UHFFFAOYSA-N CCCCCCCCCCCCNC1=CC(C)=NC(NCCCCCCCC)=N1 Chemical compound CCCCCCCCCCCCNC1=CC(C)=NC(NCCCCCCCC)=N1 JQBMXIZEJZXVFH-UHFFFAOYSA-N 0.000 description 1
- XJGLSABHTTVSAZ-UHFFFAOYSA-N CCCCCCCCCCCCNC1=CC(C2=CC=CC=C2)=NC(NCCCCCCCC)=N1 Chemical compound CCCCCCCCCCCCNC1=CC(C2=CC=CC=C2)=NC(NCCCCCCCC)=N1 XJGLSABHTTVSAZ-UHFFFAOYSA-N 0.000 description 1
- XBALMKGXMJFJJS-UHFFFAOYSA-N CCCCCCCCCCCCNC1=CC(CCC)=NC(N(C)C)=N1 Chemical compound CCCCCCCCCCCCNC1=CC(CCC)=NC(N(C)C)=N1 XBALMKGXMJFJJS-UHFFFAOYSA-N 0.000 description 1
- UWEJASOXDMEWGY-UHFFFAOYSA-N CCCCCCCCCCCCNC1=CC(CCC)=NC(NC)=N1 Chemical compound CCCCCCCCCCCCNC1=CC(CCC)=NC(NC)=N1 UWEJASOXDMEWGY-UHFFFAOYSA-N 0.000 description 1
- GIGFQAPJNGRRNZ-UHFFFAOYSA-N CCCCCCCCCCCCNC1=CC(CCC)=NC(NC2=CC=CC=C2)=N1 Chemical compound CCCCCCCCCCCCNC1=CC(CCC)=NC(NC2=CC=CC=C2)=N1 GIGFQAPJNGRRNZ-UHFFFAOYSA-N 0.000 description 1
- DDZUZEUCOIMZNU-UHFFFAOYSA-N CCCCCCCCCCCNC1=CC(CCC)=NC(NCCCCCCCC)=N1 Chemical compound CCCCCCCCCCCNC1=CC(CCC)=NC(NCCCCCCCC)=N1 DDZUZEUCOIMZNU-UHFFFAOYSA-N 0.000 description 1
- NJBFPFWUQNNPHI-UHFFFAOYSA-N CCCCCCCCN(C)C1=NC2=CC(OC)=C(OC)C=C2C(N(C)CCCCCCCC)=N1 Chemical compound CCCCCCCCN(C)C1=NC2=CC(OC)=C(OC)C=C2C(N(C)CCCCCCCC)=N1 NJBFPFWUQNNPHI-UHFFFAOYSA-N 0.000 description 1
- DOODVZYOARNAPW-UHFFFAOYSA-N CCCCCCCCNC1=CC(C(C)(C)C)=NC(NCCCCCCCC)=N1 Chemical compound CCCCCCCCNC1=CC(C(C)(C)C)=NC(NCCCCCCCC)=N1 DOODVZYOARNAPW-UHFFFAOYSA-N 0.000 description 1
- UCRZSBDIJOGHFC-UHFFFAOYSA-N CCCCCCCCNC1=CC(C)=NC(N(C)C)=N1 Chemical compound CCCCCCCCNC1=CC(C)=NC(N(C)C)=N1 UCRZSBDIJOGHFC-UHFFFAOYSA-N 0.000 description 1
- HJWIEBVLLPXIAP-UHFFFAOYSA-N CCCCCCCCNC1=CC(C)=NC(NC2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=CC(C)=NC(NC2=CC=CC=C2)=N1 HJWIEBVLLPXIAP-UHFFFAOYSA-N 0.000 description 1
- NAUTXOLSRRSMSK-UHFFFAOYSA-N CCCCCCCCNC1=CC(C)=NC(NCCCCCCCC)=N1 Chemical compound CCCCCCCCNC1=CC(C)=NC(NCCCCCCCC)=N1 NAUTXOLSRRSMSK-UHFFFAOYSA-N 0.000 description 1
- GRWFXAPMIWLKHJ-UHFFFAOYSA-N CCCCCCCCNC1=CC(C2=CC=CC=C2)=NC(NCCCCCCCC)=N1 Chemical compound CCCCCCCCNC1=CC(C2=CC=CC=C2)=NC(NCCCCCCCC)=N1 GRWFXAPMIWLKHJ-UHFFFAOYSA-N 0.000 description 1
- ZPIVHQVFCVZQNW-UHFFFAOYSA-N CCCCCCCCNC1=CC(CCC)=NC(N(C)C)=N1 Chemical compound CCCCCCCCNC1=CC(CCC)=NC(N(C)C)=N1 ZPIVHQVFCVZQNW-UHFFFAOYSA-N 0.000 description 1
- REYQBQUOZVVJKQ-UHFFFAOYSA-N CCCCCCCCNC1=CC(CCC)=NC(NC2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=CC(CCC)=NC(NC2=CC=CC=C2)=N1 REYQBQUOZVVJKQ-UHFFFAOYSA-N 0.000 description 1
- ZXDBEKBQKFTVMX-UHFFFAOYSA-N CCCCCCCCNC1=NC(CCCCCCC)=NC(C)=C1 Chemical compound CCCCCCCCNC1=NC(CCCCCCC)=NC(C)=C1 ZXDBEKBQKFTVMX-UHFFFAOYSA-N 0.000 description 1
- AXKMOUCKGCMMJC-UHFFFAOYSA-N CCCCCCCCNC1=NC(N(CC)CCO)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(N(CC)CCO)=CC(C(C)(C)C)=N1 AXKMOUCKGCMMJC-UHFFFAOYSA-N 0.000 description 1
- BGMMDORSZRNTEC-UHFFFAOYSA-N CCCCCCCCNC1=NC(N(CC)CCO)=CC(C)=N1 Chemical compound CCCCCCCCNC1=NC(N(CC)CCO)=CC(C)=N1 BGMMDORSZRNTEC-UHFFFAOYSA-N 0.000 description 1
- WOTLDBDNBYGJMB-UHFFFAOYSA-N CCCCCCCCNC1=NC(N(CC)CCO)=CC(C2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=NC(N(CC)CCO)=CC(C2=CC=CC=C2)=N1 WOTLDBDNBYGJMB-UHFFFAOYSA-N 0.000 description 1
- OKGRBCBVDHSBMN-UHFFFAOYSA-N CCCCCCCCNC1=NC(N(CC)CCO)=CC(CCC)=N1 Chemical compound CCCCCCCCNC1=NC(N(CC)CCO)=CC(CCC)=N1 OKGRBCBVDHSBMN-UHFFFAOYSA-N 0.000 description 1
- LBJIGDCQNPAUCB-UHFFFAOYSA-N CCCCCCCCNC1=NC(N(CCCC)CCCC)=CC(C)=N1 Chemical compound CCCCCCCCNC1=NC(N(CCCC)CCCC)=CC(C)=N1 LBJIGDCQNPAUCB-UHFFFAOYSA-N 0.000 description 1
- UNENELOAAIJKBY-UHFFFAOYSA-N CCCCCCCCNC1=NC(N(CCCC)CCCC)=CC(CCC)=N1 Chemical compound CCCCCCCCNC1=NC(N(CCCC)CCCC)=CC(CCC)=N1 UNENELOAAIJKBY-UHFFFAOYSA-N 0.000 description 1
- YZIFAYSPKHTIBT-UHFFFAOYSA-N CCCCCCCCNC1=NC(N2CCCC2)=C(CCCCCC)C(C)=N1 Chemical compound CCCCCCCCNC1=NC(N2CCCC2)=C(CCCCCC)C(C)=N1 YZIFAYSPKHTIBT-UHFFFAOYSA-N 0.000 description 1
- RQCSIUZMYHKQGM-UHFFFAOYSA-N CCCCCCCCNC1=NC(N2CCCC2)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(N2CCCC2)=CC(C(C)(C)C)=N1 RQCSIUZMYHKQGM-UHFFFAOYSA-N 0.000 description 1
- FFQMQUIXYZFHPH-UHFFFAOYSA-N CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1 Chemical compound CCCCCCCCNC1=NC(N2CCCC2)=CC(C)=N1 FFQMQUIXYZFHPH-UHFFFAOYSA-N 0.000 description 1
- AOQDNMLFKSIVGM-UHFFFAOYSA-N CCCCCCCCNC1=NC(N2CCCC2)=CC(C2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=NC(N2CCCC2)=CC(C2=CC=CC=C2)=N1 AOQDNMLFKSIVGM-UHFFFAOYSA-N 0.000 description 1
- KVFBMNZOGLKYLY-UHFFFAOYSA-N CCCCCCCCNC1=NC(N2CCCC2)=CC(CCC)=N1 Chemical compound CCCCCCCCNC1=NC(N2CCCC2)=CC(CCC)=N1 KVFBMNZOGLKYLY-UHFFFAOYSA-N 0.000 description 1
- ZAEAEICMLUSLTQ-UHFFFAOYSA-N CCCCCCCCNC1=NC(N2CCOCC2)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(N2CCOCC2)=CC(C(C)(C)C)=N1 ZAEAEICMLUSLTQ-UHFFFAOYSA-N 0.000 description 1
- OTNNRILYXJLGRA-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=C(CCCCCC)C(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=C(CCCCCC)C(C)=N1 OTNNRILYXJLGRA-UHFFFAOYSA-N 0.000 description 1
- RBWFOKYMKUCIFD-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=CC(C(C)(C)C)=N1 RBWFOKYMKUCIFD-UHFFFAOYSA-N 0.000 description 1
- PUYPUNLXTHDDRP-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=CC(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=CC(C)=N1 PUYPUNLXTHDDRP-UHFFFAOYSA-N 0.000 description 1
- PMHTVPHQOYPYCT-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=CC(CCC)=N1 Chemical compound CCCCCCCCNC1=NC(NCC2=CC=CC=C2)=CC(CCC)=N1 PMHTVPHQOYPYCT-UHFFFAOYSA-N 0.000 description 1
- GDKCVUNXEYFCMQ-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCC)=CC(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCC)=CC(C)=N1 GDKCVUNXEYFCMQ-UHFFFAOYSA-N 0.000 description 1
- XYFPMGVGSYPWDL-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCC)=CC(CCC)=N1 Chemical compound CCCCCCCCNC1=NC(NCCC)=CC(CCC)=N1 XYFPMGVGSYPWDL-UHFFFAOYSA-N 0.000 description 1
- YFKUKZPPEFLCRB-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCC2=CC=CC=C2)=CC(C2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=NC(NCCC2=CC=CC=C2)=CC(C2=CC=CC=C2)=N1 YFKUKZPPEFLCRB-UHFFFAOYSA-N 0.000 description 1
- PVGKMQLBQHMEGU-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCCCCCCC)=C(CCCCCC)C(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCCCCCCC)=C(CCCCCC)C(C)=N1 PVGKMQLBQHMEGU-UHFFFAOYSA-N 0.000 description 1
- UATQEDZMZXJFLU-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCCN(C)CCCN)=C(CCCCCC)C(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCCN(C)CCCN)=C(CCCCCC)C(C)=N1 UATQEDZMZXJFLU-UHFFFAOYSA-N 0.000 description 1
- ORRJEVBRIHZKDZ-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCCN(CC)CC)=C(CCCCCC)C(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCCN(CC)CC)=C(CCCCCC)C(C)=N1 ORRJEVBRIHZKDZ-UHFFFAOYSA-N 0.000 description 1
- RQZXDXFBKWFOOD-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCCN(CC)CC)=CC(C2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=NC(NCCCN(CC)CC)=CC(C2=CC=CC=C2)=N1 RQZXDXFBKWFOOD-UHFFFAOYSA-N 0.000 description 1
- OCRSDXGLOTYZGG-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCNCCCC)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCNCCCC)=CC(C(C)(C)C)=N1 OCRSDXGLOTYZGG-UHFFFAOYSA-N 0.000 description 1
- HFLIOOUZCZQZRI-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCOCCO)=C(CCCCCC)C(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCOCCO)=C(CCCCCC)C(C)=N1 HFLIOOUZCZQZRI-UHFFFAOYSA-N 0.000 description 1
- ASSRZRHYLZCBEO-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCOCCO)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCOCCO)=CC(C(C)(C)C)=N1 ASSRZRHYLZCBEO-UHFFFAOYSA-N 0.000 description 1
- IXHNNGLDWSWERX-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCOCCO)=CC(C2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=NC(NCCOCCO)=CC(C2=CC=CC=C2)=N1 IXHNNGLDWSWERX-UHFFFAOYSA-N 0.000 description 1
- DVSDIKRLPIOIPH-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCOCCOCCN)=C(CCCCCC)C(C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCOCCOCCN)=C(CCCCCC)C(C)=N1 DVSDIKRLPIOIPH-UHFFFAOYSA-N 0.000 description 1
- ZKYZSTDAFOOKFX-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCOCCOCCN)=CC(C(C)(C)C)=N1 Chemical compound CCCCCCCCNC1=NC(NCCOCCOCCN)=CC(C(C)(C)C)=N1 ZKYZSTDAFOOKFX-UHFFFAOYSA-N 0.000 description 1
- RWXUBZGKNSNDGS-UHFFFAOYSA-N CCCCCCCCNC1=NC(NCCOCCOCCN)=CC(C2=CC=CC=C2)=N1 Chemical compound CCCCCCCCNC1=NC(NCCOCCOCCN)=CC(C2=CC=CC=C2)=N1 RWXUBZGKNSNDGS-UHFFFAOYSA-N 0.000 description 1
- PNAVILANFGFRHD-UHFFFAOYSA-N CCCCCCCNC1=NC(NCCCN(CC)CC)=CC(CCC)=N1 Chemical compound CCCCCCCNC1=NC(NCCCN(CC)CC)=CC(CCC)=N1 PNAVILANFGFRHD-UHFFFAOYSA-N 0.000 description 1
- BVVWWWOCILRJCY-UHFFFAOYSA-N CCCCN(CCCC)C1=CC(CCC)=NC(N(C)C)=N1 Chemical compound CCCCN(CCCC)C1=CC(CCC)=NC(N(C)C)=N1 BVVWWWOCILRJCY-UHFFFAOYSA-N 0.000 description 1
- JPINNZJBCZXJGB-UHFFFAOYSA-N CCCCN(CCCC)C1=CC(CCC)=NC(NC2=CC=CC=C2)=N1 Chemical compound CCCCN(CCCC)C1=CC(CCC)=NC(NC2=CC=CC=C2)=N1 JPINNZJBCZXJGB-UHFFFAOYSA-N 0.000 description 1
- MFUFOEUDEFOGMS-UHFFFAOYSA-N CCN(CC)CCCNC1=CC(C2=CC=CC=C2)=NC(NC2=CC=CC=C2)=N1 Chemical compound CCN(CC)CCCNC1=CC(C2=CC=CC=C2)=NC(NC2=CC=CC=C2)=N1 MFUFOEUDEFOGMS-UHFFFAOYSA-N 0.000 description 1
- LFUWWDQCKITUQG-UHFFFAOYSA-N CN(C)C1=NC(NCCC2=CC=CC=C2)=CC(C2=CC=CC=C2)=N1 Chemical compound CN(C)C1=NC(NCCC2=CC=CC=C2)=CC(C2=CC=CC=C2)=N1 LFUWWDQCKITUQG-UHFFFAOYSA-N 0.000 description 1
- FCFATSKMPXNCJL-UHFFFAOYSA-N COC1=C(OC)C=C2C(=C1)N=C(N1CCCCC1)N=C2N1CCCCC1 Chemical compound COC1=C(OC)C=C2C(=C1)N=C(N1CCCCC1)N=C2N1CCCCC1 FCFATSKMPXNCJL-UHFFFAOYSA-N 0.000 description 1
- ZBBSUHCKKZGZFN-UHFFFAOYSA-N COC1=C(OC)C=C2C(=C1)N=C(N1CCCCCC1)N=C2N1CCCCCC1 Chemical compound COC1=C(OC)C=C2C(=C1)N=C(N1CCCCCC1)N=C2N1CCCCCC1 ZBBSUHCKKZGZFN-UHFFFAOYSA-N 0.000 description 1
- STQSBKDQCROVAA-UHFFFAOYSA-N COC1=C(OC)C=C2C(=C1)N=C(NCC1=CC=CC=C1)N=C2NCC1=CC=CC=C1 Chemical compound COC1=C(OC)C=C2C(=C1)N=C(NCC1=CC=CC=C1)N=C2NCC1=CC=CC=C1 STQSBKDQCROVAA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/28—Heterocyclic compounds containing nitrogen in the ring
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/35—Heterocyclic compounds
- D06M13/355—Heterocyclic compounds having six-membered heterocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
- Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]
Definitions
- the present invention relates to the use of substituted 2,4-bis(alkylamino)pyrimidines in the antimicrobial treatment of surfaces and to the preparation of such compounds.
- the present invention relates to the use of 2,4-bis(alkylamino)pyrimidines of formula wherein R 1 is C 1 -C 12 alkyl or C 6 -C 10 aryl; R 2 is hydrogen or C 1 -C 12 alkyl; or R 1 and R 2 together form a radical of formula wherein R′ and R′′′ are each independently of the other hydrogen, C 1 -C 6 alkyl or C 1 -C 6 alkoxy; R 3 and R 5 are each independently of the other hydrogen or C 1 -C 8 alkyl; R 4 is C 1 -C 20 alkyl, unsubstituted phenyl, C 6 -C 10 aryl, preferred C 7 -C 10 aryl; C 6 -C 10 aryl—C -
- R 6 is C 1 -C 20 alkyl, C 8 -C 10 aryl, C 6 -C 10 aryl—C 1 -C 8 alkyl, hydroxy—C 1 -Calkyl, di—C 1 -C 8 alkylamino—C 1 -Calkyl, mono—C 1 -C 6 alkylamino—C 1 -C 6 alkyl, —(CH 2 ) 2 -(O—(CH 2 ) 2 ) 1 — 4 -OH or —(CH 2 ) 2 -(O—(CH 2 ) 2 ) 1 — 4-NH 2 ; or R 3 and R 4 and/or R 5 and R 6 together form a pyrrolidine, piperidine, hexamethyleneimine or
- C 1 -C 20 Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyl, isohexyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl or eicosyl.
- alkyl e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or
- C 1 -C 12 Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, seo-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyi, isohexyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl or dodecyl.
- alkyl e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, seo-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyi, isohexyl, heptyl, octyl, isooctyl, nonyl, dec
- C 1 -C 6 Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, isohexyl, hexyl, heptyl, octyl or isooctyl.
- C 1 -C 4 Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl or tert-butyl.
- C 1 -C 8 Alkyl is straight-chain or branched alkyl, e.g. n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, isohexyl, hexyl, heptyl, octyl or isooctyl, especially hexyl.
- C 1 - 6 Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyl or isohexyl.
- C 1 -C 6 Alkoxy is a straight-chain or branched radical, e.g. methoxy, ethoxy, propoxy, butoxy, pentyloxy or hexyloxy.
- C 6 -C 10 Aryl denotes naphthyl and especially phenyl.
- C 6 -C 10 Aryl radicals may be unsubstituted or may carry one or more, for example one, two, three or four, identical or different substituents, which may be in any desired position(s). Examples of such substituents are C 1 -C 4 alkyl, halogen, hydroxy, C 1 -C4alkoxy, trifluoromethyl, cyano, hydroxycarbonyl, C 1 -C 4 —alkoxycarbonyl, aminocarbonyl, amino, C 1 -C 4 alkylamino, di—C 1 -C 4 alkylamino and C 1 -C 4 -alkylcarbonylamino.
- R 1 is C 1 -C 8 alkyl or phenyl; or to compounds of formula (1) wherein R 2 is hydrogen or C 3 -C 8 alkyl; or to compounds of formula (1) wherein R 3 and R 5 are each independently of the other hydrogen or C 1 -C 8 alkyl; or to compounds of formula (1) wherein R 4 is C 1 -C 12 alkyl, unsubstituted phenyl, C 6 -C 10 aryl—C 1 -C 6 alkyl, hydroxy—C 2 -C 6 alkyl, di—C 1 -C 4 -alkylamino—C 1 -C 4 alkyl,
- R 6 is C 1 -C 12 alkyl, C 6 -C 10 aryl, C 6 -C 10 aryl—C 1 C 6 alkyl, hydroxy—C 2 -C 6 alkyl, di—C 1 -C 4 alkylamino—C 1 -C 4 alkyl, mono—C 1 -C 4 alkylamino—C 1 -C 4 alkyl, —(CH 2 ) 2 -(O—(CH 2 ) 2) 1, 2 -OH or —(CH 2 ) 2 -(O—(CH 2 ) 2 ) 1, 2 -NH 2 ; or to compounds of formula (1) wherein R 3 and R 4 and/or R 6 and R 6 together form a pyrrolidine, piperidine, hexamethyleneimine or morpholine ring.
- R′ is hydrogen, C 1 -C 3 alkyl or C 1 -C 3 alkoxy
- R′′ is C 1-C 3 alkyl or C 1 -C 3 alkoxy
- R 3 and R 5 are each independently of the other hydrogen or C 1 -C 8 alkyl
- R 4 and R 6 are each independently of the other C 1 -C 12 alkyl, phenyl—C 1 -C 3 alkyl, hydroxy—C 1 -C 6 -alkyl
- R 3 and R 4 and/or R 5 and R 6 together form a pyrrolidine, piperidine, hexamethyleneimine or
- R 1 is C 1 -C 8 or phenyl
- R 2 is hydrogen or hexyl
- R 1 and R 2 together form a radical of formula ( 1 a ) wherein R′ is hydrogen, C 1 -C 3 alkyl or C 1 -C 3 alkoxy, and R′′ is C 1 -C 3 alkyl or C 1 -C 3 alkoxy
- R 3 and R 5 are each independently of the other hydrogen or C 1 -C 8 alkyl
- R 4 is C 1 -C 12 alkyl, unsubstituted phenyl, C 6 -C 10 aryl—C 1 -C 6 alkyl, hydroxy—C 2 -C 6 alkyl, di—C 1 -C 4 -alkylamino—C
- R 6 is C 1 -C 12 alkyl, C 6 -C 10 aryl, C 6 -C 10 aryl-C 1 -C 6 alkyl, hydroxy—C 2 C 6 alkyl, di—C 1 -C 4 alkyl—amino—C 1 -C 4 alkyl,
- Espedally preferred compounds are those of the following formulae
- the substituted 2,4-bis(alkylamino)pyrimidines are obtained by reacting the corresponding dichloropyrimidine compound (formula ( 1 b )) with a primary or secondary amine—depending upon the meanings of the radicals R 3 and R 6 —in a suitable solvent, e.g. DMF, di—oxane, toluene, xylene, ethanol or butanol, and an auxiliary base, e.g. triethylamine, DIEA, sodium carbonate, potassium carbonate, etc., or using an excess of the amine compound, for a period of from 1 to 24 hours at 40-150° C.
- a suitable solvent e.g. DMF, di—oxane, toluene, xylene, ethanol or butanol
- an auxiliary base e.g. triethylamine, DIEA, sodium carbonate, potassium carbonate, etc.
- the resulting 2-alkylamino-4hydroxy-pyrimidine is then converted into the corresponding 2-alkylamino-4-chloro-pyrimidine compound according to customary methods by means of phosphorus oxychloride.
- the substituted 2,4-alkylamino-pyrimidines are obtained by reacting the 2-alkylamino—4-chloro-pyrlmidine compound with a primary or secondary amine (R 4 R 5 NH) in a suitable solvent, e.g. methanol, ethanol, butanol, tetrahydrofuran, dimethylformamide, dioxane, toluene or xylene, and an auxiliary base, e.g.
- the 2,4-bis(alkylamino)pyrimidines used according to the invention exhibit a pronounced antimicrobial action, especially against pathogenic gram-positive and gram-negative bacteria and against bacteria of skin flora, and also against yeasts and moulds. They are therefore suitable especially in the disinfection, deodorisation and the general and antimicrobial treatment of the skin and mucosa and also of integumentary appendages (hair), more especially in the disinfection of the hands and of wounds.
- the invention therefore relates also to a personal care preparation comprising at least one compound of formula (1) as well as cosmetically tolerable carriers or adjuvants.
- the personal care preparation according to the invention contains from 0.01 to 15 % by weight, preferably from 0.1 to 10 % by weight, based on the total weight of the composition, of a compound of formula (1) and cosmetically tolerable adjuvants.
- the personal care preparation will comprise, in addition to the 2,4-bis(alkylamino)pyrimidine of formula (1), further constituents, for example sequestering agents, colourings, perfume oils, thickening or solidifying agents (consistency regulators), emollients, UV absorbers, skin-protective agents, antioxidants, additives that improve mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca and Mg salts of C 14 -C 22 fatty acids, and optionally preservatives.
- further constituents for example sequestering agents, colourings, perfume oils, thickening or solidifying agents (consistency regulators), emollients, UV absorbers, skin-protective agents, antioxidants, additives that improve mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca and Mg salts of C 14 -C 22 fatty acids, and optionally preservatives.
- the personal care preparation according to the invention may be formulated as a water-in-oil or oil-in-water emulsion, as an alcoholic or alcohol-containing formulation, as a vesicular dispersion of an ionic or non-ionic amphiphilic lipid, as a gel, a solid stick or as an aerosol formulation.
- the cosmetically tolerable adjuvant contains preferably from 5 to 50 % of an oily phase, from 5 to 20 % of an emulsifier and from 30 to 90 % water.
- the oily phase may contain any oil suitable for cosmetic formulations, e.g. one or more hydrocarbon oils, a wax, a natural oil, a silicone oil, a fatty acid ester or a fatty alcohol.
- Preferred mono- or poly-ols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol.
- Cosmetic formulations according to the invention may be used in a variety of fields. Especially the following preparations, for example, come into consideration:
- skin-care preparations e.g. skin-washing and cleansing preparations in the form of tablet-form or liquid soaps, synthetic detergents or washing pastes;
- bath preparations e.g. liquid (foam baths, milks, shower preparations) or solid bath preparations, e.g. bath cubes and bath salts;
- skin-care preparations e.g. skin emulsions, multi-emulsions or skin oils
- cosmetic personal care preparations e.g. facial make-up in the form of day creams or powder creams, face powder (loose or pressed), rouge or cream make-up, eye-care preparations, e.g. eyeshadow preparations, mascara, eyeliner, eye creams or eye-fix creams; lip-care preparations, e.g. lipsticks, lip gloss, lip contour pencils, nail-care preparations, such as nail varnish, nail varnish removers, nail hardeners or cuticle removers;
- intimate hygiene preparations e.g. intimate washing lotions or intimate sprays
- foot-care preparations e.g. foot baths, foot powders, foot creams or foot balsams, special deodorants and antiperspirants or callus-removing preparations;
- light-protective preparations such as sun milks, lotions, creams and oils, sun blocks or tropicals, pre-tanning preparations or after-sun preparations;
- skin-tanning preparations e.g. self-tanning creams
- depigmenting preparations e.g. preparations for bleaching the skin or skin-lightening preparations
- insect-repellents e.g. insect-repellent oils, lotions, sprays or sticks;
- deodorants such as deodorant sprays, pump-action sprays, deodorant gels, sticks or roll-ons;
- antiperspirants e.g. antiperspirant sticks, creams or roll-ons
- preparations for cleansing and caring for blemished skin e.g. synthetic detergents (solid or liquid), peeling or scrub preparations or peeling masks;
- hair-removal preparations in chemical form e.g. hair-removing powders, liquid hair-removing preparations, cream- or paste-form hair-removing preparations, hair removing preparations in gel form or aerosol foams;
- shaving preparations e.g. shaving soap, foaming shaving creams, non-foaming shaving creams, foams and gels, preshave preparations for dry shaving, aftershaves or after-shave lotons;
- fragrance preparations e.g. fragrances (eau de Cologne, eau de toilette, eau de perfume, perfume de toilette, perfume), perfume oils or cream perfumes;
- dental-care, denture-care and mouth-mare preparations e.g. toothpastes, gel toothpastes, tooth powders, mouthwash concentrates, anti-plaque mouthwashes, denture deaners or denture fixatives;
- cosmetic hair-treatment preparations e.g. hair-washing preparations in the form of shampoos and conditioners, hair-care preparations, e.g. pretreatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment packs, intensive hair treatments, hair-structuring preparations, e.g. hair-waving preparations for permanent waves (hot wave, mild wave, cold wave), hair-straightening preparations, liquid hair-setting preparations, hair foams, hairsprays, bleaching preparations, e.g.
- hair-washing preparations in the form of shampoos and conditioners
- hair-care preparations e.g. pretreatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment packs, intensive hair treatments, hair-structuring preparations, e.g. hair-waving preparations for permanent waves (hot wave, mild wave, cold wave), hair-straightening preparations, liquid hair-setting preparations, hair foams, hair
- An antimicrobial soap has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 0.3 to 1% by weight titanium dioxide 1 to 10% by weight stearic acid ad 100% soap base, e.g. the sodium salts of tallow fatty acid and coconut fatty acid or glycerol.
- a shampoo has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 12.0% by weight sodium laureth-2-sulfate 4.0% by weight cocamidopropyl betaine 3.0% by weight NaCI and water ad 100%.
- a deodorant has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 60% by weight ethanol 0.3% by weight perfume oil and water ad 100%.
- the invention relates also to an oral composition containing from 0.01 to 15% by weight, based on the total weight of the composition, of a compound of formula (1) and orally tolerable adjuvants.
- Example of an oral composition 10% by weight sorbitol 10% by weight glycerol 15% by weight ethanol 15% by weight propylene glycol 0.5% by weight sodium lauryl sulfate 0.25% by weight sodium methyloocyl taurate 0.25% by weight polyoxypropylene/polyoxyethylene block copolymer 0.10% by weight peppermint flavouring 0.1 to 0.5% by weight of a compound of formula (1) and 48.6% by weight water.
- the oral composition according to the invention may be, for example, in the form of a gel, a paste, a cream or an aqueous preparation (mouthwash).
- the oral composition according to the invention may also comprise compounds that release fluoride ions which are effective against the formation of caries, for example inorganic fluoride salts, e.g. sodium, potassium, ammonium or calcium fluoride, or organic fluoride salts, e.g. amine fluorides, which are known under the trade name Olafluor.
- fluoride ions which are effective against the formation of caries
- inorganic fluoride salts e.g. sodium, potassium, ammonium or calcium fluoride
- organic fluoride salts e.g. amine fluorides, which are known under the trade name Olafluor.
- the 2,4-bis(alkylamino)pyrimidines of formula (1) used according to the invention are also suitable for the treatment, especially preservation, of textile fibre materials.
- Such materials are undyed and dyed or printed fibre materials, e.g. of silk, wool, polyamide or polyurethanes, and especially cellulosic fibre materials of all kinds.
- Such fibre materials are, for example, natural cellulose fibres, such as cotton, linen, jute and hemp, as well as cellulose and regenerated cellulose.
- Preferred suitable textile fibre materials are made of cotton.
- the 2,4-bis(alkylamino)pyrimidines according to the invention are also suitable for the treatment of plastics, especially for imparting antimicrobial properties to or preserving plastics, e.g. polyethylene, polypropylene, polyurethane, polyester, polyamide, polycarbonate, latex etc..
- Plastics e.g. polyethylene, polypropylene, polyurethane, polyester, polyamide, polycarbonate, latex etc.
- Fields of use therefor are, for example, floor coverings, plastics coatings, plastics container and packaging materials; kitchen and bathroom utensils (e.g. brushes, shower curtains; sponges, bathmats), latex, filter materials (air and water filters), plastics articles used in the field of medicine, e.g. dressing materials, syringes, catheters etc., so-called “medical devices”, gloves and mattresses.
- Paper for example papers used for hygiene purposes, may also be provided with anti-microbial properties using the 2,4-bis(alkylamino)pyrimidines of formula (1) according to the invention.
- nonwovens e.g. nappies/diapers, sanitary towels, panty liners, and doths for hygiene and household uses
- nonwovens e.g. nappies/diapers, sanitary towels, panty liners, and doths for hygiene and household uses
- the 2,4-bis(alkylamino)pyrimidines of formula (1) are also used in washing and deaning formulations, e.g. in liquid and powder washing agents or softeners.
- the 2,4-bis(alkylamino)pyrimidines of formula (1) may especially also be used in household and all-purpose cleaners for deaning and disinfecting hard surfaces.
- a cleaning preparation has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 3.0% by weight octyl alcohol 4EO 1.3% by weight fatty alcohol C 8 -C 10 polyglucoside 3.0% by weight isopropanol ad 100% by weight water.
- the 2,4-bis(alkylamino)pyrimidines of formula (1) are also suitable for the antimicrobial treatment of wood and for the antimicrobial treatment of leather, the antimicrobial preservation of leather and the provision of leather with antimicrobial properties.
- the compounds according to the invention are also suitable for the protection of cosmetic products and household products from microbial spoilage.
- the 2,4bis(alkylamino)pyrImidlnes of formula (1) according to the invention are moreover capable of penetrating bloflims on living and non-living surfaces, of preventing the adhesion of bacteria to surfaces and any further build-up of the bloflim, of detaching such biofilm and/or inhibiting the further growth of the biofilm-forming micro-ogranisms in the biological matrix, or of killing such micro-organisms.
- Biofilms are understood, very generally, to be aggregations of living and dead micro-organisms, especially bacteria, that adhere to living and non-living surfaces, together with their metabolites in the form of extracellular polymeric substances (EPS matrix), e.g. polysaccharides.
- EPS matrix extracellular polymeric substances
- the activity of antimicrobial substances that normally exhibit a pronounced growth-inhiblbng or lethal action with respect to planktonic cells may be greatly reduced with respect to microorganisms that are organised in bloflims, for example because of inadequate penetration of the active substance into the biological matrix.
- this relates, very especially, to bioflims on human tooth surfaces and oral mucosa, which play a crucial role in the onset of degenerative diseases in the oral cavity, e.g. caries or periodontitis, as a result of the biofilm-forming micro-organisms or their metabolites.
- N,N′—Bis(2,4-dibenzylamino)-6-methylpyrimidine is obtained in a yield of 76%.
- N,N′-Bis(2,4-diphenylethylamino)-6-methylpyrlmidine is obtained in a yield of 98%.
- the reactions are carried out in parallel robotically. 56.3 mg of 4-chlorm-2-phenylamino-6-phenylpyrimidine (0.2 mmol) are dissolved in 0.5 ml of dioxane. 38.7 mg of diisopropylamine (0.3 mmol) and 3 mmol of amine are added thereto and the reaction mixture is heated at 85° C. for 21 hours. After cooling, the mass is extracted with 2 ml of dichioromethane and washed three times with 1.125 ml of acetic add (13% in water) and 1.2 ml of sodium hydroxide solution. The organic phases are dried and lyophillsed.
- the compounds (PY10) - (PY29) (see Table 1) are prepared according to this method. They were analysed by LC-MS.
- Nutrient medium Casein/soybean flour peptone bouillon for the preparation of the precultures of the test bacteria and yeast.
- test organisms examples include test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms, test organisms:
- test substances are predissolved in dimethyl sulfoxide (DMSO) and tested in a serial dilution of 1:2.
- DMSO dimethyl sulfoxide
- Bacteria and yeast are cultured overnight in CASO bouillon.
- test organism suspensions are adjusted to an organism count of 1-5 ⁇ 10 8 CFU/ml with 0.85% sodium chloride solution.
- the test substances are prepipetted into microtitre plates in an amount of 8 ⁇ l per well.
- the previously adjusted organism suspensions are diluted 1:100 in CASO bouillon and added to the test substances in an amount of 192 ⁇ l per well.
- test batches are incubated for 48 hours at 37° C. After incubation, the growth is deternined by reference to the turbidity of the test batches (optical density) at 620 nm in a microplate reader.
- the minimum inhibiting concentration is the concentration of substance at which (compared with the growth control) an appreciable inhibition of the growth ( ⁇ 20 % growth) of the test organisms is ascertained.
- Table 2 shows the microbiological test results: TABLE 2 Determination of the minimum inhibiting concentration in microtitre plates Compound of formula MIC sa MIC ec MIC cx MIC av (PY1) 11 >120 6 6 (PY2) 105 >120 ⁇ 3.75 26 (PY3) 43 >120 11 11 (PY4) 79 >120 20 20 (PY5) ⁇ 3.75 >120 ⁇ 3.75 ⁇ 3.75 (PY6) 51 >120 13 51 (PY7) 32 >120 4 8 (PY8) 17 34 8 8 (PY9) 5 37 ⁇ 3.75 ⁇ 3.75 (PY10) 8 >120 ⁇ 3.75 (PY11) 25 >120 ⁇ 3.75 (PY12) 32 64 ⁇ 3.75 (PY13) 9 >120 ⁇ 3.75 (PY14) 58 116 29 (PY15) 15 >120 7 (PY16) 37 >120 ⁇ 3.75 (PY17) 4 >120 ⁇ 3.75 (PY18) ⁇ 3.75 >120 ⁇ 3.
- Test organisms Staphylococcus aureus ATCC 6853 and 9144
- Test solution 1% stock solutions of all the test substances in a suitable solvent are
- Dilution medium the appropriate amount of the substances was pipetted directly into
- Test organisms Actinobacillus actinomycetemoomitans ATCC 43718
- Test solution Stock solutions of all the test substances in ethanol at 1500 ppm (w/w)
- Bacteria are removed from blood agar plates using cotton wool buds and a suitable optical density (McFarland 0.5) is adjusted in an appropriate medium; that solution is used undiluted for F. nucleatum and P. nigrescens, and in a dilution of 1:20 for the other strains. 0.1 ml of bacterial culture is added per 2 ml of active ingredient solution and incubation is carried out as described above. TABLE 4 Determination of the minimum inhibiting concentration MIC [ppm] of a broadened organism spectrum: oral organisms Compound of formula Microorganism (PY5) (PY8) (PY9) A. actinomycetemcomitans ATCC43718 >15 >15 >15 S.
Abstract
Description
- The present invention relates to the use of substituted 2,4-bis(alkylamino)pyrimidines in the antimicrobial treatment of surfaces and to the preparation of such compounds.
- The present invention relates to the use of 2,4-bis(alkylamino)pyrimidines of formula
wherein R1 is C1-C12alkyl or C6-C10aryl; R2 is hydrogen or C1-C12alkyl; or R1 and R2 together form a radical of formula
wherein R′ and R′″ are each independently of the other hydrogen, C1-C6alkyl or C1-C6alkoxy; R3 and R5 are each independently of the other hydrogen or C1-C8alkyl; R4 is C1-C20alkyl, unsubstituted phenyl, C6-C10aryl, preferred C7-C10aryl; C6-C10aryl—C- - C8alkyl, hydroxy—C1-C6alkyl, di—C1-C6alkylamino—C1-C6alkyl, mono—C1-C6alkylamino—C1-
- C8alkyl, —(CH2)2-(O—(CH2)1—4-OH or —(CH2)2-(O—(CH2)2)1—4-NH2;
- R6 is C1-C20alkyl, C8-C10aryl, C6-C10aryl—C1-C8alkyl, hydroxy—C1-Calkyl, di—C1-C8alkylamino—C1-Calkyl, mono—C1-C6alkylamino—C1-C6alkyl, —(CH2)2-(O—(CH2)2)1—4-OH or —(CH2)2-(O—(CH2)2)1—4-NH 2; or R3 and R4 and/or R5 and R6 together form a pyrrolidine, piperidine, hexamethyleneimine or
- morpholine ring; in the antimicrobial treatment of surfaces.
- C1-C20Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyl, isohexyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl or eicosyl. C1-C12Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, seo-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyi, isohexyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl or dodecyl.
- C1-C6Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, isohexyl, hexyl, heptyl, octyl or isooctyl.
- C1-C4Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl or tert-butyl.
- C1-C8Alkyl is straight-chain or branched alkyl, e.g. n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, isohexyl, hexyl, heptyl, octyl or isooctyl, especially hexyl.
- C1-6Alkyl is straight-chain or branched alkyl, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyl or isohexyl.
- C1-C6Alkoxy is a straight-chain or branched radical, e.g. methoxy, ethoxy, propoxy, butoxy, pentyloxy or hexyloxy.
- C6-C10Aryl denotes naphthyl and especially phenyl. C6-C10Aryl radicals may be unsubstituted or may carry one or more, for example one, two, three or four, identical or different substituents, which may be in any desired position(s). Examples of such substituents are C1-C4alkyl, halogen, hydroxy, C1-C4alkoxy, trifluoromethyl, cyano, hydroxycarbonyl, C1-C4—alkoxycarbonyl, aminocarbonyl, amino, C1-C4alkylamino, di—C1-C4alkylamino and C1-C4-alkylcarbonylamino.
- Special preference is given to compounds of formula (1) wherein R1 is C1-C8alkyl or phenyl; or to compounds of formula (1) wherein R2 is hydrogen or C3-C8alkyl; or to compounds of formula (1) wherein R3 and R5 are each independently of the other hydrogen or C1-C8alkyl; or to compounds of formula (1) wherein R4 is C1-C12alkyl, unsubstituted phenyl, C6-C10aryl—C1-C6alkyl, hydroxy—C2-C6alkyl, di—C1-C4-alkylamino—C1-C4alkyl,
- mono—C1-C4alkylamino—C1-C4alkyl, —(CH2)2-(O—(CH2)2)1,2-OH or
- —(CH2)2-(O—(CH2)2)1, 2-NH2; and R6 is C1-C12alkyl, C6-C10aryl, C6-C10aryl—C1C6alkyl, hydroxy—C2-C6alkyl, di—C1-C4alkylamino—C1-C4alkyl, mono—C1-C4alkylamino—C1-C4alkyl, —(CH2)2-(O—(CH2)2) 1, 2-OH or —(CH2)2-(O—(CH2)2)1, 2-NH2; or to compounds of formula (1) wherein R3 and R4 and/or R6 and R6 together form a pyrrolidine, piperidine, hexamethyleneimine or morpholine ring.
- Preference is given to the use according to the invention of compounds of formula
wherein R′ is hydrogen, C1-C3alkyl or C1-C3alkoxy; R″ is C1-C 3alkyl or C1-C3alkoxy; R3 and R5 are each independently of the other hydrogen or C1-C8alkyl; and R4 and R6 are each independently of the other C1-C12alkyl, phenyl—C1-C3alkyl, hydroxy—C1-C6-alkyl - or di—C1-C6alkylamino—C1-C6alkyl, mono—C1-C6alkylamino—C1-C6alkyl, —(CH2)2-(O—(CH2)2)1—4OH or —(CH2)2-(O—(CH2)2)1—4-NH2; or R3 and R4 and/or R5 and R6 together form a pyrrolidine, piperidine, hexamethyleneimine or
- morpholine ring.
- Special preference is given to the use of compounds of formula (1) wherein R1 is C1-C8or phenyl; R2 is hydrogen or hexyl; or R1 and R2 together form a radical of formula (1 a) wherein R′ is hydrogen, C1-C3alkyl or C1-C3alkoxy, and R″ is C1-C3alkyl or C1-C3alkoxy; R3 and R5 are each independently of the other hydrogen or C1-C8alkyl; R4 is C1-C12alkyl, unsubstituted phenyl, C6-C10aryl—C1-C6alkyl, hydroxy—C2-C6alkyl, di—C1-C4-alkylamino—C
- 1-C4alkyl, mono—C1-C4alkylamino—C1-C4alkyl, —(CH2)2-(O—(CH2)2)1,2-OH
- or —(CH2)2-(O—(CH2)2)1,2-NH2; and R6 is C1-C12alkyl, C6-C10aryl, C6-C10aryl-C1-C6alkyl, hydroxy—C2C6alkyl, di—C1-C4alkyl—amino—C1-C4alkyl,
- mono—C1-C4alkylamino—C1-C4alkyl, —(CH2)2-(O—(CH2)2)1,2-OH or —(CH2)2-(O—CH2)2)1,2-NH2; or R3 and R4 together, and R5 and R6 together, form a pyrrolidine, piperidine, hexamethyleneimine or morpholine ring.
- There are used especially compounds of formula (1) wherein R3 and R5 , and R4 and R6 , have the same meanings.
-
- Examples of compounds used according to the invention are listed in Table 1:
TABLE 1 Compound Purity Purity of formula Structure Mass GC (%) LC (%) PY1 400 25 (GC) PY2 473 80 (GC) PY3 385 78 (GC) PY4 356 100 (GC) PY5 349 98 (GC) PY6 461 35 (GC) PY7 292 100 (GC) PY8 304 100 (GC) PY9 332 100 (GC) PY10 339 97 (LC) PY11 375 50 (LC) Py12 398 70 (LC) PY13 341 94 (LC) PY14 397 90 (LC) PY15 282 96 (LC) PY16 318 82 (LC) PY17 341 60 (LC) PY18 312 98 (LC) PY19 369 84 (LC) PY20 290 97 (LC) PY21 312 85 (LC) PY22 352 89 (LC) PY23 376 96 (LC) PY24 290 99 (LC) PY25 292 92 (LC) PY26 349 88 (LC) PY27 292 93 (LC) PY28 264 77 (LC) PY29 321 93 (LC) PY30 433 68 PY31 375 97 PY32 411 26 PY33 434 58 PY34 377 84 PY35 433 77 PY36 319 99 PY37 355 77 PY38 378 73 PY39 377 65 PY40 306 32 PY41 337 91 PY42 349 90 PY43 405 83 PY44 290 99 PY45 326 51 PY46 349 72 PY47 278 55 PY48 308 90 PY49 411 87 PY50 467 90 PY51 353 97 PY52 412 94 PY53 371 57 PY54 335 85 PY55 452 49 PY56 430 40 PY57 332 70 PY58 304 78 PY59 318 65 PY60 284 48 PY61 403 74 PY62 310 78 PY63 409 61 PY64 387 56 PY65 449 28 PY66 391 93 PY67 333 90 PY68 383 90 PY69 369 75 PY70 351 94 PY71 349 91 PY72 378 87 PY73 410 48 PY74 367 92
The compounds used according to the invention are prepared according to methods known perse. The substituted 2,4-bis(alkylamino)pyrimidines are obtained by reacting the corresponding dichloropyrimidine compound (formula (1 b)) with a primary or secondary amine—depending upon the meanings of the radicals R3 and R6 —in a suitable solvent, e.g. DMF, di—oxane, toluene, xylene, ethanol or butanol, and an auxiliary base, e.g. triethylamine, DIEA, sodium carbonate, potassium carbonate, etc., or using an excess of the amine compound, for a period of from 1 to 24 hours at 40-150° C. The reaction takes place according to the following Scheme (I):
or the compounds used according to the invention are prepared by condensing a guanidine compound with a suitable β-keto ester using an auxiliary base, e.g. sodium carbonate, potassium carbonate, sodium ethanolate, sodium methanolate or potassium tert-butanolate, in a suitable solvent, e.g. methanol, ethanol, butanol, tert-butanol, tetrahydrofuran, dimethylformamide, acetonitrile, toluene or xyiene, for a period of from 1 hour to 24 hours at a temperature of from 40 to 150° C. The resulting 2-alkylamino-4hydroxy-pyrimidine is then converted into the corresponding 2-alkylamino-4-chloro-pyrimidine compound according to customary methods by means of phosphorus oxychloride. The substituted 2,4-alkylamino-pyrimidines are obtained by reacting the 2-alkylamino—4-chloro-pyrlmidine compound with a primary or secondary amine (R4R5NH) in a suitable solvent, e.g. methanol, ethanol, butanol, tetrahydrofuran, dimethylformamide, dioxane, toluene or xylene, and an auxiliary base, e.g. triethylamine, DIEA, sodium carbonate, potassium carbonate or an excess of amine, for a period of from 1 to 24 hours at a temperature of from 40 to 150° C. The reaction takes place according to the following Scheme (II):
The 2,4-bis(alkylamino)pyrimidines used according to the invention exhibit a pronounced antimicrobial action, especially against pathogenic gram-positive and gram-negative bacteria and against bacteria of skin flora, and also against yeasts and moulds. They are therefore suitable especially in the disinfection, deodorisation and the general and antimicrobial treatment of the skin and mucosa and also of integumentary appendages (hair), more especially in the disinfection of the hands and of wounds. - They are therefore suitable as antimicrobial active ingredients and preservatives in personal care preparations, for example shampoos, bath additives, hair-care products, liquid and solid soaps (based on synthetic surfadtants and salts of saturated and/or unsaturated fatty adds), lotions and creams, deodorants, other aqueous or alcoholic solutions, e.g. cleansing solutions for the skin, moist deansing dloths, oils or powders.
- The invention therefore relates also to a personal care preparation comprising at least one compound of formula (1) as well as cosmetically tolerable carriers or adjuvants. The personal care preparation according to the invention contains from 0.01 to 15 % by weight, preferably from 0.1 to 10 % by weight, based on the total weight of the composition, of a compound of formula (1) and cosmetically tolerable adjuvants.
- Depending upon the form of the personal care preparation, it will comprise, in addition to the 2,4-bis(alkylamino)pyrimidine of formula (1), further constituents, for example sequestering agents, colourings, perfume oils, thickening or solidifying agents (consistency regulators), emollients, UV absorbers, skin-protective agents, antioxidants, additives that improve mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca and Mg salts of C14-C22 fatty acids, and optionally preservatives.
- The personal care preparation according to the invention may be formulated as a water-in-oil or oil-in-water emulsion, as an alcoholic or alcohol-containing formulation, as a vesicular dispersion of an ionic or non-ionic amphiphilic lipid, as a gel, a solid stick or as an aerosol formulation.
- As a water-in-oil or oil-in-water emulsion, the cosmetically tolerable adjuvant contains preferably from 5 to 50 % of an oily phase, from 5 to 20 % of an emulsifier and from 30 to 90 % water. The oily phase may contain any oil suitable for cosmetic formulations, e.g. one or more hydrocarbon oils, a wax, a natural oil, a silicone oil, a fatty acid ester or a fatty alcohol. Preferred mono- or poly-ols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol.
- Cosmetic formulations according to the invention may be used in a variety of fields. Especially the following preparations, for example, come into consideration:
- skin-care preparations, e.g. skin-washing and cleansing preparations in the form of tablet-form or liquid soaps, synthetic detergents or washing pastes;
- bath preparations, e.g. liquid (foam baths, milks, shower preparations) or solid bath preparations, e.g. bath cubes and bath salts;
- skin-care preparations, e.g. skin emulsions, multi-emulsions or skin oils;
- cosmetic personal care preparations, e.g. facial make-up in the form of day creams or powder creams, face powder (loose or pressed), rouge or cream make-up, eye-care preparations, e.g. eyeshadow preparations, mascara, eyeliner, eye creams or eye-fix creams; lip-care preparations, e.g. lipsticks, lip gloss, lip contour pencils, nail-care preparations, such as nail varnish, nail varnish removers, nail hardeners or cuticle removers;
- intimate hygiene preparations, e.g. intimate washing lotions or intimate sprays;
- foot-care preparations, e.g. foot baths, foot powders, foot creams or foot balsams, special deodorants and antiperspirants or callus-removing preparations;
- light-protective preparations, such as sun milks, lotions, creams and oils, sun blocks or tropicals, pre-tanning preparations or after-sun preparations;
- skin-tanning preparations, e.g. self-tanning creams;
- depigmenting preparations, e.g. preparations for bleaching the skin or skin-lightening preparations;
- insect-repellents, e.g. insect-repellent oils, lotions, sprays or sticks;
- deodorants, such as deodorant sprays, pump-action sprays, deodorant gels, sticks or roll-ons;
- antiperspirants, e.g. antiperspirant sticks, creams or roll-ons;
- preparations for cleansing and caring for blemished skin, e.g. synthetic detergents (solid or liquid), peeling or scrub preparations or peeling masks;
- hair-removal preparations in chemical form (depilation), e.g. hair-removing powders, liquid hair-removing preparations, cream- or paste-form hair-removing preparations, hair removing preparations in gel form or aerosol foams;
- shaving preparations, e.g. shaving soap, foaming shaving creams, non-foaming shaving creams, foams and gels, preshave preparations for dry shaving, aftershaves or after-shave lotons;
- fragrance preparations, e.g. fragrances (eau de Cologne, eau de toilette, eau de parfum, parfum de toilette, perfume), perfume oils or cream perfumes;
- dental-care, denture-care and mouth-mare preparations, e.g. toothpastes, gel toothpastes, tooth powders, mouthwash concentrates, anti-plaque mouthwashes, denture deaners or denture fixatives;
- cosmetic hair-treatment preparations, e.g. hair-washing preparations in the form of shampoos and conditioners, hair-care preparations, e.g. pretreatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment packs, intensive hair treatments, hair-structuring preparations, e.g. hair-waving preparations for permanent waves (hot wave, mild wave, cold wave), hair-straightening preparations, liquid hair-setting preparations, hair foams, hairsprays, bleaching preparations, e.g. hydrogen peroxide solutions, lightening shampoos, bleaching creams, bleaching powders, bleaching pastes or oils, temporary, semi-permanent or permanent hair colourants, preparations containing seif-oxidising dyes, or natural hair colourants, such as henna or camomile.
- An antimicrobial soap has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 0.3 to 1% by weight titanium dioxide 1 to 10% by weight stearic acid ad 100% soap base, e.g. the sodium salts of tallow fatty acid and coconut fatty acid or glycerol.
- A shampoo has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 12.0% by weight sodium laureth-2-sulfate 4.0% by weight cocamidopropyl betaine 3.0% by weight NaCI and water ad 100%.
- A deodorant has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 60% by weight ethanol 0.3% by weight perfume oil and water ad 100%.
- The invention relates also to an oral composition containing from 0.01 to 15% by weight, based on the total weight of the composition, of a compound of formula (1) and orally tolerable adjuvants.
- Example of an oral composition: 10% by weight sorbitol 10% by weight glycerol 15% by weight ethanol 15% by weight propylene glycol 0.5% by weight sodium lauryl sulfate 0.25% by weight sodium methyloocyl taurate 0.25% by weight polyoxypropylene/polyoxyethylene block copolymer 0.10% by weight peppermint flavouring 0.1 to 0.5% by weight of a compound of formula (1) and 48.6% by weight water.
- The oral composition according to the invention may be, for example, in the form of a gel, a paste, a cream or an aqueous preparation (mouthwash).
- The oral composition according to the invention may also comprise compounds that release fluoride ions which are effective against the formation of caries, for example inorganic fluoride salts, e.g. sodium, potassium, ammonium or calcium fluoride, or organic fluoride salts, e.g. amine fluorides, which are known under the trade name Olafluor.
- The 2,4-bis(alkylamino)pyrimidines of formula (1) used according to the invention are also suitable for the treatment, especially preservation, of textile fibre materials. Such materials are undyed and dyed or printed fibre materials, e.g. of silk, wool, polyamide or polyurethanes, and especially cellulosic fibre materials of all kinds. Such fibre materials are, for example, natural cellulose fibres, such as cotton, linen, jute and hemp, as well as cellulose and regenerated cellulose. Preferred suitable textile fibre materials are made of cotton.
- The 2,4-bis(alkylamino)pyrimidines according to the invention are also suitable for the treatment of plastics, especially for imparting antimicrobial properties to or preserving plastics, e.g. polyethylene, polypropylene, polyurethane, polyester, polyamide, polycarbonate, latex etc.. Fields of use therefor are, for example, floor coverings, plastics coatings, plastics container and packaging materials; kitchen and bathroom utensils (e.g. brushes, shower curtains; sponges, bathmats), latex, filter materials (air and water filters), plastics articles used in the field of medicine, e.g. dressing materials, syringes, catheters etc., so-called “medical devices”, gloves and mattresses.
- Paper, for example papers used for hygiene purposes, may also be provided with anti-microbial properties using the 2,4-bis(alkylamino)pyrimidines of formula (1) according to the invention.
- It is also possible for nonwovens, e.g. nappies/diapers, sanitary towels, panty liners, and doths for hygiene and household uses, to be provided with antimicrobial properties in accordance with the invention.
- The 2,4-bis(alkylamino)pyrimidines of formula (1) are also used in washing and deaning formulations, e.g. in liquid and powder washing agents or softeners.
- The 2,4-bis(alkylamino)pyrimidines of formula (1) may especially also be used in household and all-purpose cleaners for deaning and disinfecting hard surfaces.
- A cleaning preparation has, for example, the following composition: 0.01 to 5% by weight of a compound of formula (1) 3.0% by weight octyl alcohol 4EO 1.3% by weight fatty alcohol C8-C10polyglucoside 3.0% by weight isopropanol ad 100% by weight water.
- In addition to preserving cosmetic and household products, the preservation of technical products, the provision of technical products with antimicrobial properties and use as a biocide in technical processes are also possible, for example in paper treatment, especially in paper treatment liquors, in printing ink thickeners consisting of starch or of cellulose derivatives, in surface-coating compositions and in paints.
- The 2,4-bis(alkylamino)pyrimidines of formula (1) are also suitable for the antimicrobial treatment of wood and for the antimicrobial treatment of leather, the antimicrobial preservation of leather and the provision of leather with antimicrobial properties.
- The compounds according to the invention are also suitable for the protection of cosmetic products and household products from microbial spoilage.
- In addition to their generally antimicrobial action, the 2,4bis(alkylamino)pyrImidlnes of formula (1) according to the invention are moreover capable of penetrating bloflims on living and non-living surfaces, of preventing the adhesion of bacteria to surfaces and any further build-up of the bloflim, of detaching such biofilm and/or inhibiting the further growth of the biofilm-forming micro-ogranisms in the biological matrix, or of killing such micro-organisms.
- Biofilms are understood, very generally, to be aggregations of living and dead micro-organisms, especially bacteria, that adhere to living and non-living surfaces, together with their metabolites in the form of extracellular polymeric substances (EPS matrix), e.g. polysaccharides. The activity of antimicrobial substances that normally exhibit a pronounced growth-inhiblbng or lethal action with respect to planktonic cells may be greatly reduced with respect to microorganisms that are organised in bloflims, for example because of inadequate penetration of the active substance into the biological matrix.
- In the present invention, this relates, very especially, to bioflims on human tooth surfaces and oral mucosa, which play a crucial role in the onset of degenerative diseases in the oral cavity, e.g. caries or periodontitis, as a result of the biofilm-forming micro-organisms or their metabolites.
- The following Examples illustrate, but do not limit, the present invention.
- 8.15 g of 2,4-dichloro-6-methyl-pyrimidine (50 mmol) are heated with 19.39 g of octylamine (150 mmol) and 20.73 g of potassium carbonate (150 mmol) in 20 ml of dioxane for 16 hours at 1009°C. After cooling, the product is taken up in 300 ml of ethyl acetate and washed with 0.5 mol/litre of sodium hydroxide solution and saturated sodium chloride solution. The product is concentrated in vacuo and then octylamine is distilled off for 2 hours at 140° C. under a rotary slide valve vacuum. 12.95 g of N,N′—bis(2,4-dioctylamino)-6-methylpyrimidine (37.15 mmol, 74.3% of theory) are obtained. The end product is analysed by NMR, HPLC—MS, GC and HPLC. GC: 98% area M+1=349 NMR (1H in DMSO): 0.85, t, 6H; 1.25, m, 20H; 1.5, m, 4H; 2, s, 3H; 4.2, m, 4H; 5.5, s, 1 H; 6.2, s, 1H; 6.6; s, 1H.
- 8.15 g of 2,4-dichloro-methyl-pyrimidine (50 mmol) are heated with 16 g of benzylamine (150 mmol) and 20.73 g of potassium carbonate (150 mmol) in 20 ml of dioxane for 16 hours at 100° C. After cooling, the product is taken up in 300 ml of ethyl acetate and washed with 0.5 mol/litre of sodium hydroxide solution and saturated sodium chloride solution. The product is concentrated in vacuo and then benzylamine is distilled off for 2 hours at from 105 to 120° C. under a rotary slide valve vacuum, and the product is recrystallised from isopropanol. N,N′—Bis(2,4-dibenzylamino)-6-methylpyrimidine is obtained in a yield of 76%. Purity: GC 100% NMR (1H in DMSO, ppm): 2, s, 3H; 4.45, m, 4H; 5.6, s, 1H; 6.95, s, 1H; 7.25, m, 11H.
- 8.15 9 of 2,4-dichloro6-methyl-pyrimidine (50 mmol) are heated with 18.17 9 of phenyl-ethylamine (150 mmol) and 20.73 g of potassium carbonate (150 mmol) in 20 ml of dioxane for 16 hours at 100° C. After cooling, the product is taken up in 300 ml of ethyl acetate and washed with 0.5 mol/litre of sodium hydroxide solution and saturated sodium chloride solution. The product is concentrated in vacuo and then phenylethylamine is distilled off for 2 hours at 150° C. under a rotary slide valve vacuum and the product is recrystallised from isopropanol. N,N′-Bis(2,4-diphenylethylamino)-6-methylpyrlmidine is obtained in a yield of 98%. Purity: GC 100% HPLC 98% NMR (I1H in DMSO, ppm): 2, s, 3H; 2.9, t, 4H; 3.45, m, 4H; 5.6, 8, 1H; 6.45, 8, IH; 6.8, 8, 1-H; 7.25, m, 10OH.
- 7 g (20 mmol) of phenylguanidine carbonate are reacted in 5 ml of absolute ethanol with 27.2 9 (80 mmol) of a 20% sodium ethanolate solution. 11.5 9 of ethylbenzoyl acetate (59.8 mmol) are added dropwise thereto in the course of 15 minutes at 75° C. The reaction mass is then stirred for 15 hours at 70° C. and, after cooling, is extracted with 50 ml of di—chloromethane and washed three times with 40 ml of water/3 ml of acetic acid. The organic phase is dried over sodium sulfate and concentrated by evaporation. 5.86 9 (55.7% of theory) of 4-hydroxy-2-phenylamino-6-phenylpyrimidine are obtained.
- NMR (1H in DMSO, ppm): 6.45, s,1H; 7.05, t, 1H; 7.4, t, 2H; 7.5, m, 3H; 7.75, d, 2H; 8, m, 2H;9,s, 11H; 11.05,s, 1H.
- 2 g (7.6 mmol) are reacted in 10 ml of toluene with 3.5 g of phosphorus oxychloride. The reaction mass is heated to 80° C and 1.53 g of triethylamine (15.1 mmol) are added dropwise thereto in the course of 20 minutes. After a reaction time of 2 hours at 800C, the mass is cooled in an ice bath and 28 ml of 4M sodium hydroxide solution are added dropwise thereto. The aqueous phase is extracted three times with ethyl acetate. After concentration of the organic phase by evaporation, 2.12 9 (99.1% of theory) of 4- chloro-2-phenyl-amino-6-phenylpyrimidine are obtained. NMR (1H in DMSO, ppm): 7, t, 1IH; 7.3, t, 2H; 7.55, m, 4H; 7.8, d, 2H; 8.2, m, 2H; 10.05, s, 11H.
- The reactions are carried out in parallel robotically. 56.3 mg of 4-chlorm-2-phenylamino-6-phenylpyrimidine (0.2 mmol) are dissolved in 0.5 ml of dioxane. 38.7 mg of diisopropylamine (0.3 mmol) and 3 mmol of amine are added thereto and the reaction mixture is heated at 85° C. for 21 hours. After cooling, the mass is extracted with 2 ml of dichioromethane and washed three times with 1.125 ml of acetic add (13% in water) and 1.2 ml of sodium hydroxide solution. The organic phases are dried and lyophillsed.
-
- 34.65 g of octylguanidine acetate A (0.15 mol) are reacted in 30 ml of ethanol with 102 g of 20% sodium ethanolate solution in ethanol (0.3 mol). The reaction mixture is heated to 75° C., and 26.15 g of methyl acetate B (0.22 mol) are added thereto in the course of one hour, and the mixture is stirred for 12 hours. After cooling, the reaction mass is diluted with dichloro-methane and washed three times with water/acetic add and twice with sodium hydroxide so- luton. The combined alkaline aqueous phases are adjusted to pH 6 with acetic acid and ex- tracted with dichloromethane, dried over sodium sulfate and concentrated by evaporation. 30.74 9 of compound C (87% of theory) are obtained. Purity in HPLC: 99% NMR (in CD2CI2 in ppm): 0.9, t, 3H; 1.3, m, 1 OH; 1.6, qt, 2H; 2.2, s, 3H; 3.35, m, 2H; 5.6, s, 1H; 6.7, s, IH.
- 18.96 g (0.08 mol) of the compound of formula C are reacted in 60 ml of toluene with 36.85 g of phosphorus oxychloride. The reaction mass is heated to 80° C. After a reaction time of 2 hours at 80° C., the mass is cooled in an Ice bath and 4M sodium hydroxide solution is added dropwise thereto. The aqueous phase is extracted three times with toluene. After concentration of the organic phase by evaporation, 20.04 g (98% of theory) of the compound of formula D are obtained. Purity in GC: 100% NMR (in CD2CI2 in ppm): 0.8, t, 3H; 1.3, m, 10H; 1.55, qt, 2H; 2.2, s, 3H; 3.3, q, 2H; 5.25, a, 1H; 6.35, s, 1H.
- 12.96 g of compound D (0.048 mol) are mixed with 6.19 g of di-isopropylamine (0.048 mol) in 60 ml of dioxane and heated at reflux. 4.9 g of pyrrolidine (0.057 mol) are added dropwise thereto in the course of 25 minutes and the reaction mixture is stirred at reflux for 29 hours. After cooling, the reaction mass is diluted with dichloromethane and washed three times with water/acetic acid and twice with sodium hydroxide solution. The organic phase is dried over sodium sulfate and concentrated by evaporation. 12.73 g of compound PY44 (91.4% of theory) are obtained. Purity in GC: 100% NMR (CD2CI2 in ppm): 0.8, t, 3H; 1.2, m, 10H; 1.45, qt, 2H; 1.85, m, 4H; 2, 5, 3H; 3.2—3.3, m (2 signals), 6H; 4.7, s, 1 H; 5.45 s, 1H.
- 18.48 g of octylguanidine acetate A (0.08 mol) are reacted in 15 ml of ethanol with 54.4 g of 20% sodium ethanolate solution in ethanol (0.1 6 mol). The reaction mixture is then heated to 75° C and 24 9 of methyl 2-hexylacetoacetate E (0.12 mol) are added thereto in the course of 30 minutes, and the mixture is sUrred overnight. After cooling, the reaction mass is diluted with dichloromethane and washed twice with water/acetic acid. The organic phase is dried over sodium sulfate and concentrated by evaporation. The crude product is recrystallised from acetone. 14.86 g of compound F (57.9% of theory) are obtained. LC-MS: a compound having M =321.
- 13.16 g (0.041 mol) of a compound of formula F are reacted in 40 ml of toluene with 18.89 g of phosphorus oxychloride. The reaction mass is heated to 80° C. After a reaction time of 2 hours at 80° C., the mass is cooled in an ice bath and 4M sodium hydroxide solution is added dropwise thereto. The aqueous phase is extracted three times with toluene.
- After concentration of the organic phase by evaporation, 13.65 g (98% of theory) of the compound of formula G are obtained. Purity in GC: 100% NMR (CD2CI2 in ppm): 0.9, m, 6H; 1.3, m, 18H; 1.5, m, 2H; 1.6, m, 2H; 2.4, 8, 3H; 2.6, t, 2H; 3.4, q, 2H; 5.6, s, 1H.
- 11.88 g of compound G (0.035 mol) are stirred with 51.87 g of 1,8-diamino—3, 6-dioxaoctane (0.35 mol) and 6.77 g of diisopropylamine (0.0525 mol) at 110° C. for 23 hours. After cooling, the reaction mass is diluted with dichloromethane and washed three times with water and twice with waterlacetic acid. The combined aqueous phases are adjusted to pH 9 with sodium hydroxide solution and extracted with dichloromethane, dried over sodium sulfate and concentrated by evaporation. 14.45 g of compound PY55 (64.6% of theory) are obtained. Purity in GC: 100% NMR (CD2CI2 in ppm): 0.9, m, 6H; 1.3, m, 20H; 1.55, m, 2H; 2.15, s, 3H; 2.3, t, 2H; 2.4, s, 2H; 2.8, t, 2H; 3.3, q, 2H; 3.45, t, 2H; 3.6, m, 8H; 5.1, s, 1H; 5.7, s, 1H.
- Nutrient medium: Casein/soybean flour peptone bouillon for the preparation of the precultures of the test bacteria and yeast.
-
-
- Bacteria: Staphylococcus aureus ATCC 6583
- Corynebacterium xerosis ATCC 373 (a)
- Actinomyces viscosus ATTC 43146
- Escherichia Coli ATTC 10536
- Bacteria: Staphylococcus aureus ATCC 6583
- The test substances are predissolved in dimethyl sulfoxide (DMSO) and tested in a serial dilution of 1:2.
- Bacteria and yeast are cultured overnight in CASO bouillon.
- All test organism suspensions are adjusted to an organism count of 1-5×108 CFU/ml with 0.85% sodium chloride solution. The test substances are prepipetted into microtitre plates in an amount of 8 μl per well.
- The previously adjusted organism suspensions are diluted 1:100 in CASO bouillon and added to the test substances in an amount of 192 μl per well.
- The test batches are incubated for 48 hours at 37° C. After incubation, the growth is deternined by reference to the turbidity of the test batches (optical density) at 620 nm in a microplate reader.
- The minimum inhibiting concentration (MIC value) is the concentration of substance at which (compared with the growth control) an appreciable inhibition of the growth (≲20 % growth) of the test organisms is ascertained.
- Three microtitre plates are used for each test organism and substance concentration.
- Table 2 shows the microbiological test results:
TABLE 2 Determination of the minimum inhibiting concentration in microtitre plates Compound of formula MIC sa MIC ec MIC cx MIC av (PY1) 11 >120 6 6 (PY2) 105 >120 <3.75 26 (PY3) 43 >120 11 11 (PY4) 79 >120 20 20 (PY5) <3.75 >120 <3.75 <3.75 (PY6) 51 >120 13 51 (PY7) 32 >120 4 8 (PY8) 17 34 8 8 (PY9) 5 37 <3.75 <3.75 (PY10) 8 >120 <3.75 (PY11) 25 >120 <3.75 (PY12) 32 64 <3.75 (PY13) 9 >120 <3.75 (PY14) 58 116 29 (PY15) 15 >120 7 (PY16) 37 >120 <3.75 (PY17) 4 >120 <3.75 (PY18) <3.75 >120 <3.75 (PY19) 32 8 8 (PY20) 29 29 15 (PY21) <3.75 >120 <3.75 (PY22) 40 >120 20 (PY23) 160 >120 40 (PY24) >120 >120 16 (PY25) 76 >120 10 (PY26) >120 >120 15 (PY27) >120 >120 60 (PY28) 40 160 10 (PY29) 10 >120 <3.75 PY30 16.5 >120 16.5 8.25 PY31 <3.75 >120 <3.75 <3.75 PY32 19.5 >120 <3.75 <3.75 PY33 <3.75 9.75 <3.75 <3.75 PY34 8 >120 <3.75 <3.75 PY35 17 34 8.5 8.5 PY36 <3.75 >120 <3.75 <3.75 PY37 <3.75 >120 <3.75 <3.75 PY38 33 66 8.25 8.25 PY39 <3.75 >120 <3.75 <3.75 PY40 9 >120 <3.75 <3.75 PY41 64 >120 64 64 PY42 <3.75 >120 <3.75 <3.75 PY43 27 54 13.5 6.75 PY44 <3.75 30 <3.75 <3.75 PY45 <3.75 58 <3.75 <3.75 PY46 7.25 >120 <3.75 <3.75 PY47 <3.75 35 <3.75 <3.75 PY48 32 128 8 8 PY49 64 >120 32 16 PY50 64 64 32 16 PY51 >120 >120 <3.75 <3.75 PY52 9.25 9.25 <3.75 <3.75 PY53 108 >120 <3.75 <3.75 PY54 <3.75 36 <3.75 <3.75 PY55 <3.75 <3.75 <3.75 <3.75 PY56 18.5 9.25 <3.75 <3.75 PY57 9.5 >120 <3.75 <3.75 PY58 17 >120 <3.75 <3.75 PY59 19.5 >120 9.75 9.75 PY60 27 >120 13.5 6.75 PY61 18.5 >120 9.25 9.25 PY62 76 >120 19 9.5 PY63 8.75 >120 <3.75 <3.75 PY64 36 >120 <3.75 <3.75 PY65 <3.75 <3.75 <3.75 <3.75 PY66 <3.75 >120 <3.75 7 PY67 <3.75 >120 <3.75 <3.75 PY68 6.25 >120 <3.75 <3.75 PY69 <3.75 >120 <3.75 <3.75 PY70 31 >120 <3.75 <3.75 PY71 9 >120 <3.75 <3.75 PY72 31 15.5 <3.75 <3.75 PY73 18 18 <3.75 <3.75 PY74 34 >120 8.5 8.5 - Medium: Caseinisoybean flour peptone agar ( Merck) *Sabouraud 4% glucose agar (Merck)
- Dilution medium: sterile 0.85% NaCI solution
- Test organisms: Staphylococcus aureus ATCC 6853 and 9144
-
- Staphylococcus epidermidis ATCC 12228
- C. xerosis ATCC 373 **
- C. minutissimum ATCC 23348
- Proplonibacterium acnes ATCC 6919
- Escherichia coli ATCC 10536 and NCTC 8196
- Proteus vulgaris ATCC 6896
- Klebsiella pneumoniae ATCC 4352
- Salmonella choleraesuis ATCC 9184
- Pseudomonas aeruginosa ATCC 15442
- *Candida albicans ATCC 10231
- *Aspergillus niger ATCC 6275
- Incubation: 24 hours at 37° C.
-
- *3 days at 28° C.
- Test solution: 1% stock solutions of all the test substances in a suitable solvent are
-
- prepared and diluted in serial dilutions (1:10, 1:100 and 1:1000 dilution),
- where possible diluted to such an extent that the end concentrations
- in agar are from 500 ppm to 10 ppm.
- Test principle:
- 0.3 ml of the dilution stage in question is mixed with 15 ml of still-liquid nutrient medium. When the nutrient substrate has solidified, 10 μl portions of a suitable organism dilution of the test strains in 0.85% NaCI solution are spotted onto the agar medium:
TABLE 3 Determination of the minimum inhibiting concentration MIC [ppm] of a broadened organism spectrum Compound of formula Microorganism (PY5) (PY8) (PY9) Staphylococcus aureus ATCC 6538 3.91 31.25 7.8 Staphylococcus aureus ATCC 9144 3.91 31.25 7.8 Staphylococcus epidermidis ATCC 12228 3.91 31.25 7.8 C. xerosis ATCC 373** 7.81 7.8 1.95 C. minutissimum ATCC 23348 3.91 15.63 3.9 Propionibacterium acnes ATCC 6919*** 3.91 31.25 7.8 Escherichia coli NCTC 8196 >1000 31.25 15.63 Escherichia coli ATCC 10536 >1000 62.5 250 Proteus vulgaris ATCC 6896 >1000 >500 >500 Klebsiella pneumoniae ATCC 4352 250 15.63 7.8 Salmonella choleraesuis ATCC 9184 >1000 62.5 250 Pseudomonas aeruginosa ATCC 15442 >1000 >500 >500 Candida albicans ATCC 10231 >1000 250 62.5 Aspergillus niger ATCC 6275 >1000 250 250 -
TABLE 3a Determination of the minimum inhibiting concentration MIC°[ppm] of a broadened organism spectrum Microorganisms (PY44) (PY55) Staphylococcus aureus ATCC 6538 7.8 7.8 Staphylococcus aureus ATCC 9144 7.8 3.9 Staphylococcus epidermidis ATCC 12228 3.9 7.8 C. xerosis ATCC 373** 3.9 3.9 C. minutissimum ATCC 23348** 3.9 3.9 Propionibacterium acnes ATCC 6919*** 3.9 3.9 Escherichia coli NCTC 8196 15.63 7.8 Escherichia coli ATCC 10536 62.5 7.8* Proteus vulgaris ATCC 6896 >500 >500 Klebsiella pneumoniae ATCC 4352 7.8 15.63 Salmonella choleraesuis ATCC 9184 62.5 7.8 Pseudomonas aeruginosa ATCC 15442 >500 >500 Candida albicans ATCC 10231 250 125 Aspergillus niger ATCC 6275 500 500
*very slow growth, no growth in the next dilution stage
**3 days incubation,
***3 days incubation under anaerobic conditions
- Medium: thioglycolate bouillon with hemin and menadione
-
- Columbia bouillon with hemin and menadione for P. gingivalis
- and P. nigrescens
- Dilution medium: the appropriate amount of the substances was pipetted directly into
-
- the medium.
- Test organisms: Actinobacillus actinomycetemoomitans ATCC 43718
-
- Streptococcus gordonil ATCC 10558
- Streptococcus mutans ATCC 33402
- Actinomyces viscosus ATCC 43146
- Fusobacterium nucleatum subsp. polymorphum ATCC 10953
- Porphyromonas gingivalis ATCC 33277
- Prevotella nigrescens ATCC 33563
- Incubation: 7-10 days at 37° C anaerobic, or 24 hours aerobic with 10% CO2 for
-
-
- Streptococci and A. actinomycetemcomitans
-
- Test solution: Stock solutions of all the test substances in ethanol at 1500 ppm (w/w)
-
- are used.
- Test princlple:
- Bacteria are removed from blood agar plates using cotton wool buds and a suitable optical density (McFarland 0.5) is adjusted in an appropriate medium; that solution is used undiluted for F. nucleatum and P. nigrescens, and in a dilution of 1:20 for the other strains. 0.1 ml of bacterial culture is added per 2 ml of active ingredient solution and incubation is carried out as described above.
TABLE 4 Determination of the minimum inhibiting concentration MIC [ppm] of a broadened organism spectrum: oral organisms Compound of formula Microorganism (PY5) (PY8) (PY9) A. actinomycetemcomitans ATCC43718 >15 >15 >15 S. gordonii ATCC 10558 15 >15 15 S. mutans ATCC 33402 3.75 >15 15 A. viscosus ATCC 43146 3.75 3.75 3.75 F. nucleatum subsp. Polymorphum >15 15 15 ATCC 10953 P. gingivalis ATCC 3277 7.5 15 7.5 P. nigrescens ATCC 33563 15 15 7.5 Microorganism (PY44) (PY55) A. actinomycetemcomitans ATCC 43718 >15 15 S. gordonii ATCC 10558 7.5 3.8 S. mutans ATCC 33402 7.5 7.5 A. viscosus ATCC 43146 3.8 3.8 F. nucleatum subsp. polymorphum 3.8 7.5 ATCC 10953 P. gingivalis ATCC 3277 3.8 3.8 P. nigrescens ATCC 33563 3.8 3.8
Claims (22)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03102296 | 2003-07-25 | ||
EP03102296.5 | 2003-07-25 | ||
EP03102296 | 2003-07-25 | ||
PCT/EP2004/051516 WO2005011758A2 (en) | 2003-07-25 | 2004-07-16 | Use of substituted 2,4-bis (alkylamino) pyrimidines or -quinazolines as antimicrobials |
Publications (2)
Publication Number | Publication Date |
---|---|
US20060188453A1 true US20060188453A1 (en) | 2006-08-24 |
US7722893B2 US7722893B2 (en) | 2010-05-25 |
Family
ID=34112473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/565,545 Expired - Fee Related US7722893B2 (en) | 2003-07-25 | 2004-07-16 | Use of substitute 2,4-bis (alkylamino) pyrimidines or quinzolines as antimicrobials |
Country Status (12)
Country | Link |
---|---|
US (1) | US7722893B2 (en) |
EP (1) | EP1648524B1 (en) |
JP (1) | JP2007500683A (en) |
KR (1) | KR20060052806A (en) |
CN (1) | CN100441228C (en) |
AT (1) | ATE420667T1 (en) |
BR (1) | BRPI0412915A (en) |
DE (1) | DE602004019094D1 (en) |
ES (1) | ES2320772T3 (en) |
MX (1) | MXPA06000771A (en) |
TW (1) | TWI329640B (en) |
WO (1) | WO2005011758A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012055483A1 (en) * | 2010-10-28 | 2012-05-03 | Clariant International Ltd | Non-metal tanning process |
US9850227B2 (en) | 2011-02-25 | 2017-12-26 | Yuhan Corporation | Diaminopyrimidine derivatives and processes for the preparation thereof |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1648875A1 (en) * | 2003-07-30 | 2006-04-26 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
HN2005000795A (en) * | 2004-10-15 | 2010-08-19 | Aventis Pharma Inc | PYRIMIDINS AS ANTAGONISTS OF PROSTAGLANDINA D2 RECEPTOR |
EP1940804A2 (en) | 2005-10-14 | 2008-07-09 | NeuroSearch A/S | Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
EP1963284A1 (en) * | 2005-12-07 | 2008-09-03 | NeuroSearch A/S | Novel quinazoline-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
US7797509B2 (en) * | 2007-01-11 | 2010-09-14 | Netlogic Microsystems, Inc. | Systems and methods for utilizing an extended translation look-aside buffer having a hybrid memory structure |
KR101682417B1 (en) * | 2011-02-25 | 2016-12-06 | 주식회사유한양행 | Diaminopyrimidine derivatives and processes for the preparation thereof |
US9783903B2 (en) * | 2013-12-06 | 2017-10-10 | Rohm And Haas Electronic Materials Llc | Additives for electroplating baths |
CN104997782B (en) * | 2015-06-16 | 2018-02-23 | 北京师范大学 | Applications of the DBeQ in Candida albicans mycelial growth is suppressed |
CN106087103B (en) * | 2016-07-28 | 2018-06-08 | 杭州纱农纺织有限公司 | A kind of fiber of antibacterial uvioresistant and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2674598A (en) * | 1952-01-17 | 1954-04-06 | Monsanto Chemicals | 2-amino-4-methyl-6-alkylamino-pyrimidines and salts thereof |
US4116674A (en) * | 1974-08-05 | 1978-09-26 | Imperial Chemical Industries Limited | Process of severely damaging or killing unwanted plants with pyrimidine compounds |
US5550240A (en) * | 1992-06-09 | 1996-08-27 | Richter Gedeon Vegyeszeti Gyar Rt. | Piperazinyl-bis(alkylamino)pyrimidine derivatives and process for preparing same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB935381A (en) * | 1958-12-15 | 1963-08-28 | Wellcome Found | 2, 4-diaminoquinazolines and their preparation |
DE2403165A1 (en) | 1974-01-23 | 1975-07-31 | Wacker Chemie Gmbh | PESTICIDE |
DE3717480A1 (en) * | 1987-05-23 | 1988-12-01 | Shell Agrar Gmbh & Co Kg | Novel herbicidal and microbicidal 2,6-diaminopyrimidines |
TW440563B (en) * | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
-
2004
- 2004-07-16 ES ES04766240T patent/ES2320772T3/en active Active
- 2004-07-16 KR KR1020067000734A patent/KR20060052806A/en not_active Application Discontinuation
- 2004-07-16 EP EP20040766240 patent/EP1648524B1/en not_active Not-in-force
- 2004-07-16 CN CNB2004800216316A patent/CN100441228C/en not_active Expired - Fee Related
- 2004-07-16 BR BRPI0412915 patent/BRPI0412915A/en not_active IP Right Cessation
- 2004-07-16 DE DE200460019094 patent/DE602004019094D1/en active Active
- 2004-07-16 US US10/565,545 patent/US7722893B2/en not_active Expired - Fee Related
- 2004-07-16 MX MXPA06000771A patent/MXPA06000771A/en active IP Right Grant
- 2004-07-16 JP JP2006521569A patent/JP2007500683A/en active Pending
- 2004-07-16 WO PCT/EP2004/051516 patent/WO2005011758A2/en active Application Filing
- 2004-07-16 AT AT04766240T patent/ATE420667T1/en not_active IP Right Cessation
- 2004-07-23 TW TW93121984A patent/TWI329640B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2674598A (en) * | 1952-01-17 | 1954-04-06 | Monsanto Chemicals | 2-amino-4-methyl-6-alkylamino-pyrimidines and salts thereof |
US4116674A (en) * | 1974-08-05 | 1978-09-26 | Imperial Chemical Industries Limited | Process of severely damaging or killing unwanted plants with pyrimidine compounds |
US5550240A (en) * | 1992-06-09 | 1996-08-27 | Richter Gedeon Vegyeszeti Gyar Rt. | Piperazinyl-bis(alkylamino)pyrimidine derivatives and process for preparing same |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012055483A1 (en) * | 2010-10-28 | 2012-05-03 | Clariant International Ltd | Non-metal tanning process |
US8801804B2 (en) | 2010-10-28 | 2014-08-12 | Stahl International B.V. | Non-metal tanning process |
US9850227B2 (en) | 2011-02-25 | 2017-12-26 | Yuhan Corporation | Diaminopyrimidine derivatives and processes for the preparation thereof |
US9890138B2 (en) | 2011-02-25 | 2018-02-13 | Yuhan Corporation | Diaminopyrimidine derivatives and processes for the preparation thereof |
US10640490B2 (en) | 2011-02-25 | 2020-05-05 | Yuhan Corporation | Diaminopyrimidine derivatives and processes for the preparation thereof |
Also Published As
Publication number | Publication date |
---|---|
DE602004019094D1 (en) | 2009-03-05 |
CN100441228C (en) | 2008-12-10 |
ES2320772T3 (en) | 2009-05-28 |
EP1648524B1 (en) | 2009-01-14 |
WO2005011758A3 (en) | 2005-04-28 |
TW200510340A (en) | 2005-03-16 |
TWI329640B (en) | 2010-09-01 |
WO2005011758A2 (en) | 2005-02-10 |
BRPI0412915A (en) | 2006-09-26 |
KR20060052806A (en) | 2006-05-19 |
JP2007500683A (en) | 2007-01-18 |
CN1829538A (en) | 2006-09-06 |
MXPA06000771A (en) | 2006-04-18 |
ATE420667T1 (en) | 2009-01-15 |
EP1648524A2 (en) | 2006-04-26 |
US7722893B2 (en) | 2010-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7731985B2 (en) | 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces | |
US7722893B2 (en) | Use of substitute 2,4-bis (alkylamino) pyrimidines or quinzolines as antimicrobials | |
US6814960B1 (en) | Hydroxystilbene compounds used as microbicidal active substances | |
US7015228B2 (en) | 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances | |
US6730655B2 (en) | Biphenyl diquaternary ammonium compounds | |
EP1254903B1 (en) | 4-Amino-2-(pyridin-2-yl)pyrimidine as microbicidal active substances | |
US6689372B1 (en) | Microbicidal active substances | |
US7208597B2 (en) | Pyridyl-triazine derivatives as microbiocidal active substances | |
US6346260B1 (en) | Microbicidal active ingredients | |
US6624182B1 (en) | Hydroxyphenylvinylthiazoles | |
US20040006061A1 (en) | Alkoxybenzylamine | |
US20070196407A1 (en) | Alkoxyphenylcarboxylic acid derivatives | |
US20060052375A1 (en) | Bis-alkylbenzylamines | |
US7078550B2 (en) | Silanyl phenols and naphthols | |
US6967215B2 (en) | Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof | |
US7476753B2 (en) | 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives | |
US6743940B2 (en) | 4-aminobut-2-ynecarboxylic acid derivatives | |
EP1074179B1 (en) | Microbicidal active ingredients | |
EP1215198A1 (en) | 4-Aminobut-2-yne carboxylic acid derivatives and their use as antimicrobial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CIBA SPECIALTY CHEMICALS CORP.,NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARQUAIS-BIENEWALD, SOPHIE;HOLZL, WERNER;PREUSS, ANDREA;AND OTHERS;SIGNING DATES FROM 20051120 TO 20051128;REEL/FRAME:018743/0948 Owner name: CIBA SPECIALTY CHEMICALS CORP., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARQUAIS-BIENEWALD, SOPHIE;HOLZL, WERNER;PREUSS, ANDREA;AND OTHERS;REEL/FRAME:018743/0948;SIGNING DATES FROM 20051120 TO 20051128 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20140525 |